However, in RA due to the activators (TNF-α, IL-17, etc.), IκB is phosphorylated, ubiquitinated by IκB kinase, and eventually degraded by the enzyme, releasing NF-κB. The gene discussed is IL17A; the disease is rheumatoid arthritis.